Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1996Journal of Medical Virology

Duration of protection from clinical hepatitis A disease after vaccination with VAQTA®

View Full Paper
Ask AI
Bookmark
Share

Authors

BWBrian L. WiensLewis and Clark Pharmaceuticals (United States)NBNorman R. BohidarJohnson & Johnson (United States)JPJoseph G. PigeonVillanova University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wiens et al. (1996) studied this question.

synapsesocial.com/papers/6a99a05f2a5b83337daba531https://doi.org/10.1002/(sici)1096-9071(199607)49:3<235::aid-jmv13>3.0.co;2-b
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prevention of Endemic Icteric Viral Hepatitis by Administration of Immune Serum Gamma Globulin1987 · 71 citations
  2. 2HEPATITIS A VIRUS INFECTION IN HOUSEHOLDS1982 · 80 citations
  3. 3Inactivated hepatitis A vaccine: Reactogenicity, immunogenicity, and long‐term antibody persistence1994 · 159 citations